Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Randomized Controlled Trial1
- Clinical Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Med Klin1
Search Results
Sort by
- Bookedited by Alethia Jones and Virginia Eubanks ; with Barbara Smith.Summary: "'Not a memoir, a biography, nor a reader. It is a reflection and a conversation. It is also a montage of forty years of documents, interviews and articles that provide useful lessons for social justice work' ... As an organizer, writer, publisher, scholar-activist and elected official, Barbara Smith has played key roles in multiple social justice movements, including Civil Rights, feminism, lesbian and gay liberation, anti-racism, and Black feminism. Her four decades of grassroots activism forged collaborations that introduced the idea that oppression must be fought on a variety of fronts simultaneously, including gender, race, class and sexuality. By combining ... historical documents with new unpublished interviews with fellow activists, this book uncovers the deep roots of today's 'identity politics' and 'intersectionality' and serves as an essential primer for practising solidarity and resistance"--Publisher's description.
Contents:
Chronicling an activist life
Home grown : early roots of activism
Building Black feminism
Building Black women's studies
Building Kitchen Table Press
Building multi-issue movements
Building progressive urban politics
"Took Root, Bore Fruit" : legacies and futures of a Black feminist life.Digital Access 2014 - ArticleMagliulo E, Gagliardi B, Fiori GP.Med Klin. 1978 Jul 14;73(28-29):1060-5.In a double blind study carried out under standard conditions at two treatment centers silymarin, 2 sugar-coated tablets 70 mg three times daily, showed a definite therapeutic influence on the characteristic increased serum levels of bilirubin, GOT and GPT associated with acute viral hepatitis. The above mentioned values in 28 patients treated with silymarin were compared with those in 29 patients treated with placebo. The laboratory parameters in the silymarin group regressed more than in the placebo group after the 5th day of treatment. The number of patients having attained normal values after 3 weeks' treatment was higher in the silymarin group than in the placebo group. A statistical comparison revealed a difference between bilirubin and GOT values in the placebo and silymarin groups and a definite trend in the regression of GPT values in favour of silymarin. The course of the immune reaction in HBS Ag patients was not influenced by silymarin. As already proved by other investigators, the use of silymarin in acute viral hepatitis can lead to an accelerated regression in pathological values, thus indicating its use in the treatment of this liver disease.